Amanta Healthcare Limited

AMANTA NSE Healthcare Pharmaceuticals
₹197.75
-2.00%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Return on equity is moderate at 10.3%.
  • Return on capital employed is moderate at 11.6%.
  • Net profit margin is 5.2%.
  • Profit has compounded about 22% a year over five years.
  • Sales have compounded about 11% a year over five years.
  • Promoters hold a majority stake (63.79%).

!Watch-points

  • Higher leverage: debt-to-equity of 1.11 is above 1.
  • Recent profit growth (-4%) is slower than the five-year pace (22%).

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreGrey zone
2.15

This middle range was less conclusive in Altman’s study — neither clearly safe nor clearly distressed.

Computed without the working-capital term (current-asset split not available for this stock).

Piotroski F-ScoreModerate
5 / 7

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 7 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap₹ 768 Cr
Current Price₹ 197.75
High / Low₹ 209.95 / 92.00
Stock P/E52.314816
Book Value₹ 56.70
Dividend Yield0%
ROCE11.60%
ROE10.30%
Face Value₹ 10.00
Debt to Equity1.11
PEG Ratio0.44
EV / EBITDA12.81
Industry PE35.70
P/B Ratio3.0853121
EPS₹ 3.83
Debt₹ 244 Cr
PAT Margin5.21%
Cash PAT₹ 34 Cr
ICR2.86
Promoter Holding63.79%
FII Holding0.43%
DII Holding12.92%
Public Holding22.84%

Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).

Compounded Sales Growth
10 Years
5 Years 11.00%
3 Years 4.00%
TTM 7.00%
Compounded Profit Growth
10 Years
5 Years 22.00%
3 Years 114.00%
TTM -4.00%
Stock Price CAGR
10 Years
5 Years
3 Years
1 Year 41.00%
Return on Equity
10 Years
5 Years 4.00%
3 Years 10.00%
Last Year 10.00%
Educational data only. Not a recommendation to buy, sell or hold any security.